JPH0439999B2 - - Google Patents

Info

Publication number
JPH0439999B2
JPH0439999B2 JP57097596A JP9759682A JPH0439999B2 JP H0439999 B2 JPH0439999 B2 JP H0439999B2 JP 57097596 A JP57097596 A JP 57097596A JP 9759682 A JP9759682 A JP 9759682A JP H0439999 B2 JPH0439999 B2 JP H0439999B2
Authority
JP
Japan
Prior art keywords
cell
cells
cell line
crl8118
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57097596A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58216125A (ja
Inventor
Tsutomu Abe
Hiromitsu Sakae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP57097596A priority Critical patent/JPS58216125A/ja
Priority to DE8383105615T priority patent/DE3379055D1/de
Priority to EP83105615A priority patent/EP0096839B1/en
Publication of JPS58216125A publication Critical patent/JPS58216125A/ja
Priority to US06/750,199 priority patent/US4833077A/en
Publication of JPH0439999B2 publication Critical patent/JPH0439999B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP57097596A 1982-06-09 1982-06-09 ヒト抗体の産生方法 Granted JPS58216125A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP57097596A JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法
DE8383105615T DE3379055D1 (en) 1982-06-09 1983-06-08 Method for producing human antibody
EP83105615A EP0096839B1 (en) 1982-06-09 1983-06-08 Method for producing human antibody
US06/750,199 US4833077A (en) 1982-06-09 1985-07-01 Method for producing human antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57097596A JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法

Publications (2)

Publication Number Publication Date
JPS58216125A JPS58216125A (ja) 1983-12-15
JPH0439999B2 true JPH0439999B2 (https=) 1992-07-01

Family

ID=14196612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57097596A Granted JPS58216125A (ja) 1982-06-09 1982-06-09 ヒト抗体の産生方法

Country Status (1)

Country Link
JP (1) JPS58216125A (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133125A (ja) * 1984-07-25 1986-02-17 Morinaga & Co Ltd ヒト単クロ−ン性抗肺ガン細胞抗体
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
JPS6187630A (ja) * 1984-10-08 1986-05-06 Teijin Ltd 単純ヘルペスウイルスに対するヒトモノクロ−ナル抗体及びその製造法
JPS61155398A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
JPH0720885B2 (ja) * 1985-09-27 1995-03-08 帝人株式会社 単純ヘルペスウイルス感染症の予防又は治療剤
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
JPH0695949B2 (ja) * 1987-09-08 1994-11-30 工業技術院長 ヒトＩｇＧ１型モノクローン抗体
PL2400298T3 (pl) * 2010-05-28 2014-01-31 Hoffmann La Roche Sposób hodowania pojedynczych komórek b oraz wytwarzania swoistych przeciwciał

Also Published As

Publication number Publication date
JPS58216125A (ja) 1983-12-15

Similar Documents

Publication Publication Date Title
Lake et al. Production and characterization of cytotoxic Thy‐1 antibody‐secreting hybrid cell lines Detection of T cell subsets
Lefebvre et al. Retinoic acid stimulates regeneration of mammalian auditory hair cells
Raghavachar et al. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.
Fellous et al. Induction of HLA expression in Daudi cells after cell fusion
US4434230A (en) Human nonsecretory plasmacytoid cell line
CA1229791A (fr) Composition medicamenteuse a base de fragments fc d'igg humaines
Merola et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression
JPH0198478A (ja) ＩｇＧモノクローナル抗体−生産性ハイブリドマ
JPS6362518B2 (https=)
EP0093436B1 (de) Verfahren zur Herstellung permanenter tierischer und humaner Zellinien und deren Verwendung
EP0049611B1 (en) A t-cell growth factor, and a process of producing the same
Bartal et al. Methods of hybridoma formation
JPH0439999B2 (https=)
Dausset et al. HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS: III. Genetic Definition of the DL-A System of Canine Histocompatibility, with Particular Reference to the Comparative Immunogenicity of the Major Transplantable Organs
Linsenmayer et al. Production of monoclonal antibodies to collagens and their immunofluorescence localization in embryonic cornea and cartilage
JPH114685A (ja) 冬眠特異的タンパク質産生樹立細胞株およびその創製方法
DE3786673T2 (de) Verfahren zur entfernung unerwünschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikörper und dafür geeigneter kit.
JPS59169492A (ja) ヒト融合細胞からの生理活性物質の産生方法
US4833077A (en) Method for producing human antibody
JPS59175896A (ja) ヒト抗体産生方法
Ahmed et al. Characterization of Mason-Pfizer virus induced cell transformation in vitro
Moser et al. Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells
Papageorge et al. Expression of the defective “S+ L−” type murine sarcoma virus genome in human amnion and lung cells
Nasi et al. Isolation and properties of DMSO resistant variant clones of Friend leukemia cells
CS276448B6 (cs) Způsob výroby permanentních buněčných lini-í živočišného i lidského původu